Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mylan Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (31)
Section 14, TGO91 consent (6)
Australian public assessment report (AusPar) (1)
Prescription medicine registration (1)

Date

2021 (2)
2020 (8)
2019 (1)
2018 (28)

Search

Sponsor content

39 result(s) found, displaying 11 to 20

INFLUVAC TETRA (Mylan Health Pty Ltd)

19 June 2019

Prescription medicine registration

Active ingredients: influenza virus haemagglutinin.
AusPAR: Influenza virus haemagglutinin (vaccine)

10 September 2018

Australian public assessment report (AusPar)

Australian Public Assessment Report for Influenza virus haemagglutinin (vaccine)
Mylan Health Pty Ltd - Lice prevention solution Cancelled under Section 41GL(d) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
Mylan Health Pty Ltd - Lice treatment shampoo Cancelled under Section 41GL(d) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
Mylan Health Pty Ltd - Lice removal kit Cancelled under Section 41GL(d) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
Mylan Health Pty Ltd - Comb, lice Cancelled under Section 41GL(d) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
BRUFEN SYRUP Ibuprofen 100mg/5mL oral liquid bottle Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
ODRIK trandolapril 0.5 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
ODRIK trandolapril 1 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd
ODRIK trandolapril 2 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2018

Cancellation by sponsor

Requested by Mylan Health Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.